ETF Managers Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $478K | Sell |
318,596
-35,395
| -10% | -$53.1K | 0.02% | 459 |
|
|
2022
Q4 | $414K | Buy |
353,991
+24,165
| +7% | +$28.3K | 0.02% | 395 |
|
|
2022
Q3 | $373K | Buy |
329,826
+24,892
| +8% | +$28.2K | 0.01% | 525 |
|
|
2022
Q2 | $491K | Buy |
304,934
+112,307
| +58% | +$181K | 0.01% | 497 |
|
|
2022
Q1 | $289K | Sell |
192,627
-15,108
| -7% | -$22.7K | 0.01% | 544 |
|
|
2021
Q4 | $519K | Buy |
+207,735
| New | +$519K | 0.01% | 515 |
|